Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, has secured $100 million in Series F funding and announced Mike Alvarez as the company's newly appointed CEO.
Georgian led the round with participation from Canaan, Health Catalyst Capital, and other investors and business partners.
Alvarez formerly held the CEO role at Qardio, a remote patient monitoring...
Diabetes management company Glooko is partnering with Copenhagen-based Hedia to integrate its app into Glooko's remote monitoring platform.
The Hedia Diabetes Assistant allows patients to input their blood glucose, meals and activity levels and provides bolus insulin dosing recommendations. Under the partnership, the app will integrate with Glooko's platform, which lets patients share diabetes...
Hong Seng's eMedAsia, CLEA partner to provide virtual COVID-19 screening for international travel
Malaysian digital health platform eMedAsia has started offering online COVID-19 testing services through its partnership with CLEA Technology.
Its partner provides virtual COVID-19 RTK and PCR screening services via the CLEADOC mobile app. It serves travellers who are seeking COVID-19 tests as a pre-...
Digital diabetes management company Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform.
DIABNEXT's app tracks patient diabetes metrics, allowing providers to monitor that data and provide care remotely. Glooko said it will offer its own platform and DIABNEXT, rebranded as Glooko XT, for the French market.
"We are very pleased to welcome the DIABNEXT team to Glooko and...
Digital diabetes and chronic condition management company Glooko announced Monday it had acquired Berlin-based xbird, maker of AI-based diabetes care tools.
xbird monitors patients' activity with sensors and wearables, using artificial intelligence and machine learning to find potential problems and alert users to take action, like a nudge to check blood glucose levels.
"xbird and Glooko are a...
The digital health industry experienced a big growth year in 2021. According to Rock Health’s third quarter analysis of the space, funding had already reached $21.3 billion across 541 deals. The year surpassed 2020’s full-year funding total after the second quarter.
Russ Johannesson, CEO of diabetes and chronic condition management company Glooko, told MobiHealthNews the COVID-19 pandemic...
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
Digital diabetes management company Glooko has announced the appointments of a new CCO and COO.
The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier, he will be in charge of key strategic partners and revenue generation for Glooko.
“As the leader in diabetes data management, Glooko is integrated with more diabetes and health devices than any other platform in the...
On Friday the American Diabetes Association is set to kick of its annual scientific session in San Francisco. Diabetes focused organizations have already begun to make announcements ahead of the show. MobiHealthNews compiled a roundup of the diabetes-related news coming out this week.
GLOOKO, T1D TEAM UP
This morning, diabetes management platform Glooko announced that it is teaming up with...
